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SUMMARY:  36 
We present an in vitro model to assess olfactory ensheathing glia (OEG) neuroregenerative 37 
capacity, after neural injury. It is based on a coculture of axotomized adult retinal ganglion 38 
neurons (RGN) on OEG monolayers and subsequent study of axonal regeneration, by analyzing 39 
RGN axonal and somatodendritic markers. 40 
 41 
  42 
 43 
 44 
   
ABSTRACT:  45 
Olfactory ensheathing glia (OEG) cells are localized all the way from the olfactory mucosa to and 46 
into the olfactory nerve layer (ONL) of the olfactory bulb. Throughout adult life, they are key for 47 
axonal growing of newly generated olfactory neurons, from the lamina propria to the ONL. Due 48 
to their pro-regenerative properties, these cells have been used to foster axonal regeneration in 49 
spinal cord or optic nerve injury models. 50 
We present an in vitro model to assay and measure OEG neuroregenerative capacity after neural 51 
injury. In this model, reversibly immortalized human OEG (ihOEG) is cultured as a monolayer, 52 
retinas are extracted from adult rats and retinal ganglion neurons (RGN) are cocultured onto the 53 
OEG monolayer. After 96h, axonal and somatodendritic markers in RGNs are analyzed by 54 
immunofluorescence and the number of RGNs with axon and the mean axonal length/neuron 55 
are quantified. 56 
This protocol has the advantage over other in vitro assays that rely on embryonic or postnatal 57 
neurons, that it evaluates OEG neuroregenerative properties in adult tissue. Also, it is not only 58 
useful for assessing the neuroregenerative potential of ihOEG but can be extended to different 59 
sources of OEG or other glial cells. 60 
  61 
  62 
INTRODUCTION:  63 
Adult central nervous system (CNS) neurons have limited regenerative capacity after injury or 64 
disease. A common strategy to promote CNS regeneration is transplantation, at the injury site, 65 
of cell types that induce axonal or neuronal growth such as stem cells, Schwann cells, astrocytes 66 
or olfactory ensheathing glia (OEG) cells1-5.  67 
OEG derives from the neural crest6 and locates in the olfactory mucosa and in the olfactory bulb. 68 
In the adult, olfactory sensory neurons die regularly as the result of environmental exposure and 69 
they are replaced by newly differentiated neurons. OEG surrounds and guides these new 70 
olfactory axons to enter the olfactory bulb and to establish new synapses with their targets in 71 
the CNS7.  Due to these physiological attributes, OEG has been used in models of CNS injury such 72 
as spinal cord or optic nerve injury and its neuroregenerative and neuroprotective properties 73 
become proven8-11. Several factors have been identified as responsible of the pro-regenerative 74 
characteristics of these cells, including extracellular matrix proteases production or secretion of 75 
neurotrophic and axonal growth factors12-14. 76 
Given the technical limitations to expand primary OEG cells, our group previously established and 77 
characterized reversible immortalized human OEG (ihOEG) clonal lines, which provide an 78 
unlimited supply of homogeneous OEG. These ihOEG cells derive from primary cultures, prepared 79 
from olfactory bulbs obtained in autopsies. They were immortalized by transduction of the 80 
telomerase catalytic subunit (TERT) and the oncogene Bmi-1 and modified with the SV40 virus 81 
large T antigen15-18. Two of these ihOEG cell lines are Ts14, which maintains the regenerative 82 
capacity of the original cultures and Ts12, a low regenerative line that is used as a low 83 
regeneration control in these experiments18. 84 
To assess OEG capacity to foster axonal regeneration after neural injury, several in vitro models 85 
have been implemented. In these models, OEG is applied to cultures of different neuronal origin 86 
and neurite formation and elongation, in response to glial coculture, are assayed. Examples of 87 
such neuronal sources are neonatal rat cortical neurons19, scratch wounds performed on rat 88 
   
embryonic neurons from cortical tissue20, rat retinal explants21, rat hypothalamic or hippocampal 89 
postnatal neurons22,23, postnatal rat dorsal root ganglion neurons24, postnatal mouse 90 
corticospinal tract neurons25, human NT2 neurons26 or postnatal cerebral cortical neurons on 91 
reactive astrocyte scar-like cultures27. 92 
In these models, however, the regeneration assay relies on embryonic or postnatal neurons, 93 
which have an intrinsic plasticity that is absent in injured adult neurons. To overcome this 94 
drawback, we present a model of adult axonal regeneration in cocultures of OEG lines with adult 95 
retinal ganglion neurons (RGNs), based on the one originally developed by Wigley et al.28-31 and 96 
modified and used by our group 12-18, 32, 33. Briefly, retinal tissue is extracted from adult rats and 97 
digested with papain. Retinal cell suspension is then plated on either polylysine-treated 98 
coverslips or onto Ts14 and Ts12 monolayers. Cultures are maintained for 96 h before they are 99 
fixed and then immunofluorescence for axonal (MAP1B and NF-H proteins)34 and 100 
somatodendritic (MAP2A and B)35 markers is performed. Axonal regeneration is quantified as 101 
percentage of neurons with axon, respect to total population of RGNs and axonal regeneration 102 
index is calculated as mean axonal length per neuron. This protocol is not only useful for assessing 103 
the neuroregenerative potential of ihOEG but can be extended to different sources of OEG or 104 




NOTE: Animal experimentation was approved by national and institutional bioethics committees.  109 
 110 
1. ihOEG (Ts12 and Ts14) culture.  111 
NOTE: This procedure is done under sterile conditions in a tissue culture biosafety cabinet. 112 
1. Prepare 50 mL ME10 OEG culture medium as provided in Table 1. 113 
2. Prepare 5 mL of DMEM/F12-FBS, as provided in Table 1, in a 15 mL conical tube. 114 
3. Temperate both media at 37 ºC in a clean water bath, for 15 min. 115 
4. Thaw Ts12 and Ts14 cells vials at 37 ºC in a clean water bath. 116 
5. Resuspend and add cells to the DMEM/F12-FBS culture medium prepared in Step 117 
2. 118 
6. Centrifuge for 5 min at 300 x g. 119 
7. Aspire the supernatant. 120 
8. Add 500 µL of ME10 medium and resuspend the pellet. 121 
9. Prepare a p60 cell culture dish with 3 mL of ME10 and add the cellular suspension, 122 
dropwise. 123 
10. Move to distribute the cells uniformly across the plate. 124 
11. Culture cells at 37 ºC in 5% CO2. 125 
 126 
NOTE: After reaching confluence, at least another passage must be done to optimize cells 127 
for coculture. 90% confluence is needed before seeding them on coverslips for coculture. 128 
A confluent p-60 has a mean cell number of 7 x 105 for Ts14 and 2.5 x 106 for Ts12 cell lines. 129 
Ts12 and Ts14 cell lines should be passaged every 2-3 days. 130 
 131 
 132 
   
2. Preparation of ihOEG (Ts12 and Ts14) for the assay.  133 
NOTE: This step must be done 24 h before RGN dissection and coculture. 134 
1. Treat 12 mm Ø coverslips with 10 µg/mL poly-L-lysine (PLL) for 1 h.  135 
             NOTE: Coverslips can be left O.N.in PLL solution. 136 
2. Wash coverslips with phosphate buffer saline (PBS) 1X, three times. 137 
3. Detach Ts12 and Ts14 ihOEG cells from p60 cell culture dish: 138 
3.1  Add 4 mL of DMEM/F12-FBS culture medium (see Table 1) to a 15 mL 139 
conical tube. Temperate at 37 ºC in a clean water bath. 140 
3.2 Remove medium from plates and wash cells with 1 mL PBS-EDTA 1X, 141 
once.  142 
3.3 Add 1 mL trypsin-EDTA to the OEG cells and incubate for 3-5 min at 37 143 
ºC, 5% CO2. 144 
3.4 Collect cells with a p1000 pipette and transfer them to medium 145 
prepared in step 3.1. 146 
3.5 Centrifuge for 5 min at 200 x g. 147 
3.6 Aspire the supernatant. 148 
3.7 Add 1 mL of ME10 medium and resuspend the pellet. 149 
3.8 Count cell number in a hemocytometer. 150 
4. Seed 80,000 Ts14 cells or 100,000 Ts12 cells onto coverslips in 24 well plates 151 
in 500 µL of ME10 medium. 152 
5. Culture cells at 37 ºC in 5% CO2, for 24 h. 153 
 154 
3. Retinal tissue dissection. 155 
NOTE: 2-month old male Wistar rats are used as RGN source. Two retinas (one rat) for 20 156 
wells of a 24 well cell dish. 157 
NOTE: Autoclave surgical material before use.  158 
NOTE: Papain dissociation kit is commercially purchased (Table of Materials). Follow 159 
provider´s instructions for reconstitution.  160 
NOTE: Reconstitute D,L-2-amino-5-phosphonovaleric acid (APV) in 5 mM stock and 161 
prepare aliquots. 162 
1. On the day of the assay, prepare the following media: 163 
1.1 A p60 cell culture dish with 5 mL of cold EBSS (vial 1 of the papain 164 
dissociation kit).  165 
1.2 A p60 cell culture dish with: 166 
1.2.1 Reconstituted vial 2 (papain) of the papain dissociation kit 167 
plus 50 µL of APV. 168 
1.2.2 250 µL of vial 3 (DNAse) plus 5 µL of APV. 169 
1.3 In a sterile tube mix 2.7 mL vial 1 with 300 µL vial 4 (albumin-170 
ovomucoid protease inhibitor). Add 150 µL vial 3 (DNAse) plus 30 µL 171 
APV. 172 
1.4 20 mL of Neurobasal-B27 medium (NB-B27) as provided in Table 1. 173 
2. Sacrifice a rat by asphyxiation with CO2. 174 
3. Remove the head by decapitation with guillotine, place it in a 100 mm Petri 175 
dish and spray the head with ethanol 70% before placing it in a laminar flow 176 
   
hood. 177 
4. Cut the rat´s whiskers with scissors so they do not interfere with the eye 178 
manipulation. 179 
5. Grip the optic nerve with forceps to pull out the eyeball enough to be able to 180 
make an incision across the eye with a scalpel. 181 
6. Remove the lens and vitreous humor and pull out the retina (orange-like 182 
tissue), while the remaining layers of the eye stay inside (including the pigment 183 
epithelial layer).   184 
7. Place the retina in the p60 cell culture dish prepared in Step 3.1.1. 185 
8. Transfer the retina to the p60 cell culture dish prepared in Step 3.1.2 and cut 186 
it with the scalpel in small pieces of an approximate size < 1 mm. 187 
9. Transfer to a 15 mL plastic tube. 188 
10. Incubate the tissue for 30 min, in a humidified incubator at 37 ºC under 5% 189 
CO2, with agitation every 10 min. 190 
11. Dissociate cell clumps by pipetting up and down with a glass Pasteur pipette. 191 
12. Centrifuge the cell suspension at 200 x g for 5 min. 192 
13. Discard supernatant and to inactivate papain, resuspend the cell pellet in the 193 
solution prepared in step 3.1.3. (NOTE: 1.5 mL for 2 eyes).  194 
14. Pipet carefully this cell suspension onto 5 mLµ of reconstituted vial 4.  195 
15. Centrifuge at 200 x g for 5 min. 196 
16. While centrifuging, completely remove the ME-10 medium from the OEG 24 197 
well cell plate (previously prepared in Step 2 of the protocol - Preparation of 198 
ihOEG (Ts12 and Ts14) for the assay -) and replace it with 500 µL of NB-B27 199 
medium, per well.  200 
17. Discard supernatant and resuspend the cells in 2 mL of NB-B27 medium.  201 
18. Plate 100 µL of retinal cell suspension, per well of the m24 plate, onto PLL-202 
treated or OEG monolayers-coverslips.  203 
19. Maintain cultures at 37 ºC with 5% CO2 for 96 h in NB-B27 medium. 204 
 205 
4. Immunostaining 206 
1. After 96 h, fix cells for 10 min by adding the same volume of 4% paraformaldehyde 207 
(PFA) in PBS1X to the culture medium (600 µL) (PFA final concentration 2%).  208 
2. Remove media and PFA from 24 multiwell plate and add again 500 µL of 4% 209 
paraformaldehyde (PFA) in PBS1X. Incubate for 10 min.  210 
3. Discard fixer and wash 3 times with PBS1X for 5 min. 211 
4. Block with 0,1% Triton X-100/1% FBS in PBS (PBS-TS) for 30-40 min. 212 
5. Prepare primary antibodies in PBS-TS buffer as follows: 213 
5.1  SMI31 (against MAP1B and NF-H proteins) monoclonal antibody (1:500). 214 
5.2  514 (recognizes MAP2A and B proteins) rabbit polyclonal antiserum 215 
(1:400). 216 
6. Add primary antibodies to cocultures and incubate overnight at 4 ºC.  217 
7. Next day, discard antibodies and wash coverslips with PBS1X, 3 times, for 5 min. 218 
8. Prepare secondary antibodies in PBS-TS buffer as follows: 219 
8.1 For SMI-31, anti-mouse Alexa Fluor 488 (1:500). 220 
   
8.2 For 514, anti-rabbit Alexa-594 (1:500). 221 
9. Incubate cells with the corresponding fluorescent secondary antibodies for 1h, at 222 
RT, in the dark. 223 
10. Wash coverslips with PBS1X, 3 times, for 5 min, in the dark. 224 
11. Finally, mount coverslips with mounting medium (see Table of Materials) and keep 225 
at 4ºC.  226 
NOTE: Whenever necessary, fluorescent nuclei staining with DAPI (4,6-diamidino-2-227 
phenylindole) may be performed. Before mounting, incubate cells for 10 min in the dark 228 
with DAPI (10 µg/mL in PBS1X). Wash coverslips 3 times with PBS1X and finally, mount 229 
coverslips with mounting medium. 230 
 231 
5. Axonal regeneration quantification 232 
NOTE: Samples are quantified under the 40x objective of an epifluorescence microscope. A 233 
minimum of 30 pictures should be taken on random fields, with at least 200 neurons, to be 234 
quantified for each treatment. Each experiment should be repeated a minimum of three 235 
times. 236 
1. Quantify the percentage of neurons with axon (SMI31 positive neurite) relative to 237 
total population of RGNs (identified with MAP2A/B 514 positive immunostaining of 238 
neuronal body and dendrites).  239 
2. Quantify the axonal regeneration index or mean axonal length (µm/neuron). This 240 
parameter is defined as the sum of the lengths (in µm) of all identified axons, 241 
divided by the total number of counted neurons, whether they presented an axon or 242 
not. Axonal length is determined using the plugin NeuronJ of the image software 243 
ImageJ (NIH-USA). 244 
3. Calculate mean, standard deviation, and statistical significance using appropriate 245 
software. 246 
 247 
REPRESENTATIVE RESULTS: 248 
In this protocol we present an in vitro model to assay OEG neuroregenerative capacity after 249 
neuronal injury. As shown in Figure 1, the OEG source is a reversible immortalized human OEG 250 
clonal cell line -Ts14 and Ts12-, which derives from primary cultures, prepared from olfactory 251 
bulbs obtained in autopsies15, 17, 18. Retinal tissue is extracted from adult rats, digested and retinal 252 
ganglion neurons (RGN) suspension is plated on either PLL-treated coverslips or onto ihOEG 253 
monolayers, Ts14 or Ts12. Cultures are maintained for 96 h before they are fixed. Axonal and 254 
somatodendritic markers are analyzed by immunofluorescence and axonal regeneration is 255 
quantified. 256 
 257 
Figure 1. Diagram of rat retinal ganglion neurons with olfactory ensheathing glia cells coculture, 258 
as a model of adult axonal regeneration. Immortalized human OEG (ihOEG) clonal cell lines -259 
Ts12 and Ts14- derive from primary cultures from olfactory bulbs. Retinal ganglion neurons from 260 
adult rats are plated on either PLL-treated coverslips (negative control) or onto Ts14 or Ts12 261 
monolayers. Cultures are maintained for 96 h before they are fixed and axonal and 262 
somatodendritic markers are analyzed by immunofluorescence. Percentage of neurons with axon 263 
   
and mean axonal length/neuron are quantified to assay RGN axonal regeneration.  264 
 265 
Ts14 OEG identity is assessed by immunostaining with markers described to be expressed in 266 
ensheathing glia (Figure 2), such as S100 β (2A) and vimentin (2B); GFAP expression was also 267 
analyzed to discard astrocyte contamination (2C). As shown, Ts14 expressed S100 β and vimentin 268 
but not GFAP.  269 
 270 
Figure 2. Identity of ihOEG cell line Ts14.  Immunofluorescence images of Ts14 in culture, labeled 271 
with anti-S100 β (panel A, green) and vimentin (panel B, red). GFAP expression (panel C, red) was 272 
also analyzed to discard astrocyte contamination.  Nuclei are stained with DAPI (blue). 273 
 274 
In the axonal regeneration assay, Ts14 regenerative capacity is compared to Ts12 in RGN-OEG 275 
cocultures, using PLL substrate as a negative control (Figure 3).  Both the percentage of cells with 276 
axons as well as the average length of the regenerated axons were significantly higher in neurons 277 
cocultured on Ts14 monolayers, compared to neurons plated on either Ts12 cells or PLL (3D, E). 278 
Representative images show a lack of capacity of RGN to regenerate their axons over PLL or Ts12 279 
cells (3A, B), while Ts14 stimulates the outgrowth of axons in RGN (3C). 280 
 281 
Figure 3. Assay for axonal regeneration in cocultures of OEG lines with adult retinal ganglion 282 
neurons (RGNs). (A-C) Immunofluorescence images showing somatodendritic labelling with 514 283 
antibody, which recognizes microtubule-associated protein MAP2A and B, in red, and with axon-284 
specific SMI31 antibody in green, against MAP1B and NF-H proteins. Green arrows indicate RGN 285 
axons (SMI31-positive: green) and yellow arrows indicate neuronal bodies and dendrites (514 286 
positive: red and yellow). (D, E) Graphs show mean and standard deviation of the percentage of 287 
neurons exhibiting axons and the axonal regeneration index, a parameter reflecting the mean 288 
axonal length (µM) of axons per neuron. A minimum of 30 pictures (40x) were taken on random 289 
fields and quantified for each cell sample. Experiments were performed in triplicate, from three 290 
different rats (N=3), retinal tissue pooled from both eyes, with duplicates for each experimental 291 
condition (each glia population tested). Asterisks indicate the statistical significance: *p < 0.05, 292 
**p < 0.01, ***p < 0.001, NS: non significance (ANOVA and post hoc Tukey test comparisons 293 
between parameters quantified for Ts14 vs Ts12, Ts14 vs PLL and Ts12 vs PLL).  294 
 295 
 296 
DISCUSSION:  297 
OEG transplantation at CNS injury sites is considered a promising therapy for CNS injury due to 298 
its constitutive pro-neuroregenerative properties7-9. However, depending on the tissue source -299 
olfactory mucosa (OM-OEG) versus olfactory bulb (OB-OEG) -  or age of donor, considerable 300 
variation exists in such capacity26, 31, 33, 36. Therefore, it is of importance to have an easy and 301 
reproducible in vitro model to assay the neuroregenerative capacity of a given OEG sample, 302 
before initiating in vivo studies. In the protocol described in this work, adult rat axotomized RGN 303 
are cocultured onto a monolayer of the OEG to assay. Subsequent analysis of RGN axonal and 304 
somatodendritic markers by immunofluorescence is performed to assess RGN axonal 305 
regeneration.  306 
An initial difficulty of the assay is the source of OEG. In this work we use reversible immortalized 307 
   
human OEG (ihOEG) clonal lines, previously established and characterized by our group15-18, 308 
which provide an unlimited supply of homogeneous OEG. Two of these ihOEG cell lines are Ts14, 309 
which maintains the regenerative capacity of the original cultures and Ts12, a low regenerative 310 
line that is used as a low regeneration control in these experiments18 Nevertheless, although 311 
technical limitations exist to expand human primary OEG cells, they can also be obtained from 312 
nasal endoscopic biopsies – OM- or, in case of OB-OEG, from cadaver donors. 313 
Preparation of monolayer OEG cultures is a crucial procedure, as too many cells could cause the 314 
coculture to detach from the plate. Therefore, previously to OEG preparation for the assay, it is 315 
recommended that the user determines the optimal number of cells to be plated, depending on 316 
their size and division rate.  317 
Another critical issue is retinal tissue dissociation, after retina dissection. It is necessary to break 318 
up the tissue fragments, following incubation in the dissociation mix. If done too vigorously cells 319 
will be destroyed, but tissue fragments will be left intact if done too weakly. In order to obtain a 320 
homogeneous cell suspension, we suggest filling and emptying a Pasteur pipette for 10-15 times, 321 
with a tip of intermediate diameter, while avoid bubbling. Pasteur pipettes with wide tips can be 322 
narrowed by using a Bunsen burner. 323 
To assess the capacity of different glial populations to foster adult neurons axonal regeneration, 324 
we have determined that 96h is the time interval that best suits our aim because: 1) it is the 325 
longest time to maintain  the culture alive without disturbing the OEG  monolayer; 2) it is the 326 
time needed for neurons to grow axons long enough to reveal differences between the 327 
regenerative capacities of different OEG populations or other non-regenerative cells, i.e. 328 
fibroblasts12-18,32,33. It would certainly be interesting to determine the time course of the 329 
regeneration process, as it could provide information about the differential regenerative 330 
properties of the different glial populations, at shorter times of the co-culture. In our hands, for 331 
regenerative glia, the time course between 72-96 h is quite similar for all the cell lines, although 332 
axons are shorter at 72 h (unpublished data). Also, 96 h of co-culture, permits to study OEG-333 
dependent mechanisms of adult axonal regeneration12,14.  334 
During axonal regeneration quantification, it is important to take a minimum of thirty pictures at 335 
400 augments (40x objective), at different random areas of the coverslip, but following the 336 
complete axons of the photographed neurons. Therefore, the experimenter must take serial 337 
pictures in the chosen areas, to measure the real axonal lengths. 338 
Other in vitro approaches have also been developed to evaluate OEG regenerative functions. In 339 
these models, OEG is applied to cultures of different neuronal origin and, in response to glial 340 
coculture, neurite formation and elongation are assayed19-27. However, the regeneration assay 341 
relies on embryonic or postnatal neurons, which have an intrinsic plasticity absent from injured 342 
adult neurons. Our model of adult axonal regeneration in cocultures of OEG lines with adult 343 
retinal ganglion neurons (RGNs) overcomes this drawback. In addition, we are dissecting adult 344 
retinas, and because we cut optic nerve and axons retract in the process of dissection, we obtain 345 
neuronal bodies clean of myelin, to perform the coculture. This is the difference with other parts 346 
of the adult CNS, where myelin can hinder very much the dissection to obtain clean neurons for 347 
the coculture.  348 
Based on the one originally developed by Wigley et al28-31, we highlight the following 349 
improvements in our protocol. First, the use of neurobasal medium supplemented with B27 as 350 
OEG-RGN coculture medium, which allows growth of neuronal cells and positively affects the 351 
   
reproducibility of the experiment. Second, we characterize and quantify axonal regeneration by 352 
using a specific marker of the axonal compartment; and third, we use an additional direct 353 
parameter, the mean axonal length/neuron, that assesses the axonal growth regenerative 354 
potential of OEG. 355 
In summary, we consider this is a simple, reproducible, time saving and medium-cost assay, not 356 
only useful for assessing the neuroregenerative potential of ihOEG, but also because it can be 357 
extended to different sources of OEG or other glial cells.  Moreover, it could be used as a valuable 358 
proof of concept of the neuroregenerative potential of an OEG or glial sample, before translation 359 
to in vivo or clinical studies.  360 
 361 
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